Inventor · disambiguated record
Michael M. Dubreuil
Also filed as: DUBREUIL MICHAEL M · DUBREUIL MICHAEL MAYNE
2 granted patents·3 pending applications·2 citations·filing 2020–2023
46Inventor score
Top patents by PatentIndex Score
5 records- 0188US11304978B2Compositions and methods for the treatment of cancer using a CD8 engineered T cell therapyPACT PHARMA INC·Filed 2020·Granted Apr 19, 2022·2 cites·24 claims
- 0272US12247061B2Compositions and methods for the treatment of cancer using a CD8 engineered T cell therapyADOC SSF LLC·Filed 2022·Granted Mar 11, 2025·0 cites·11 claims
- 0365US2021085720A1Compositions and methods for the treatment of cancer using a tet2 engineered t cell therapyPACT PHARMA INC·Filed 2020·Application pending·0 cites
- 0460US2024066063A1COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER USING A TGFßRII ENGINEERED T CELL THERAPYPACT PHARMA INC·Filed 2023·Application pending·0 cites
- 0559US2023355762A1Compositions and methods for the treatment of cancer using next generation engineered t cell therapyPACT PHARMA INC·Filed 2023·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michael M. Dubreuil files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →